-
D595466-100mgDSPE-PEG-2K-Boronate.
-
D595466-250mgDSPE-PEG-2K-Boronate.
-
D596707-100mgDSPE-PEG-2K-CH2COOH is a PEG derivative containing DSPE and biotin end groups. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic
-
D596707-1gDSPE-PEG-2K-CH2COOH is a PEG derivative containing DSPE and biotin end groups. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic
-
D596707-250mgDSPE-PEG-2K-CH2COOH is a PEG derivative containing DSPE and biotin end groups. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic
-
D596717-1gDSPE-PEG-2K-Maleimide is a PEG derivative with a DSPE moiety and maleimide group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic
-
D596717-500mgDSPE-PEG-2K-Maleimide is a PEG derivative with a DSPE moiety and maleimide group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic
-
D595359-1gDSPE-PEG-3.4K-Amine is a PEG derivative containing a DSPE moiety and an amine functional group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of
-
D595359-500mgDSPE-PEG-3.4K-Amine is a PEG derivative containing a DSPE moiety and an amine functional group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of
-
D595359-5gDSPE-PEG-3.4K-Amine is a PEG derivative containing a DSPE moiety and an amine functional group. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of
-
D595786-1gDSPE-PEG-3.4K-Biotin is a PEG derivative containing DSPE and biotin end groups. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic
-
D595786-500mgDSPE-PEG-3.4K-Biotin is a PEG derivative containing DSPE and biotin end groups. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic